Bladder Cancer Death Risk Higher in Patients with Blood Type A
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
Computed tomography (CT) scans prior to radical cystectomy for invasive bladder cancer may be useful.
Review indicates that doctors who operate the night before another surgery do well.
Bladder cancer patients with and without a history of pelvic irradiation have similar recurrence-free and cancer-specific survival rates.
Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Researchers found similar post-surgical outcomes between bladder cancer patients having primary and salvage radical cystectomy.
A prolonged hospital stay and discharge to a nursing facility were among the risks.
Individual cognitive factors accounted for half of all contributing human factor nano-codes.
The most common cause is respiratory compromise.
Current and former smokers are at higher risk of complications within 30 days after radical prostatectomy or cystectomy.